SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gujarat Themis Biosyn informs about appointment of CFO

05 Jan 2023 Evaluate

Gujarat Themis Biosyn has informed that the Board of Directors at its meeting held today, considered and approved the appointment of Tapas Guha Thakurata as the Chief Executive Officer (CEO) of the Company– Key Managerial Personnel under the provisions of the Companies Act, 2013 and rules there under. The company has annexed the disclosures pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) 2015 read with SEBI circular no CIR/CFD/CMD/4/2015 dated 09th September, 2015 relating to appointment of Tapas Guha Thakurata as the CEO (Annexure I). The company has commenced from 10:30 am and concluded on 10:48 am.

The above information is a part of company’s filings submitted to BSE.

Guj. Themis Biosyn Share Price

319.45 15.45 (5.08%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×